[Initial and mid-term results of coronary angioplasty in early post-infarction unstable angina]

J P Metzger1, X Tabone, C le Feuvre

  • 1Clinique cardiologique de l'hôpital Necker, Paris.

Archives Des Maladies Du Coeur Et Des Vaisseaux
|March 1, 1990
PubMed

Insights

Percutaneous transluminal coronary angioplasty (PTCA) is effective for early post-infarction unstable angina, with a 92% success rate. Acute coronary occlusion is a key risk, but long-term outcomes are favorable.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Clinical Research

Context:

  • Early management of unstable angina post-myocardial infarction.
  • Assessing interventions in a high-risk cardiac patient group.
  • Evaluating percutaneous transluminal coronary angioplasty (PTCA) efficacy and safety.

Purpose:

  • To evaluate the immediate success and medium-term outcomes of PTCA in patients with unstable angina following a heart attack.
  • To identify specific risks associated with PTCA in this early post-infarction period.
  • To determine the long-term clinical results and need for further interventions.

Summary:

  • A study of 36 patients undergoing 248 PTCA procedures for early post-infarction unstable angina showed a 92% primary success rate.
  • Acute coronary occlusion occurred in 25% of cases, more frequently in transmural infarcts and post-thrombolysis patients, requiring repeat PTCA.
  • No deaths or reinfarctions occurred during a mean 9-month follow-up, with 71% maintaining good results from PTCA alone.

Impact:

  • PTCA offers a successful treatment option for early post-infarction unstable angina with favorable medium-term results.
  • Understanding risks like acute coronary occlusion guides procedural management and patient selection.
  • The findings support PTCA as a viable alternative to emergency bypass surgery in select cases.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina II: Classification01:27

Angina II: Classification

Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...